Both in Pharmaceuticals
Xeris Biopharma Holdings vs Sarepta Therapeutics,
Over the past year XERS returned +4.5% and SRPT returned −24.2%; their daily moves had a correlation of 0.13.
XERS +4.5% SRPT −24.2%Growth of $1, one year, split-adjusted
| Metric | XERS | SRPT |
|---|---|---|
| Price | $10.35 | $18.54 |
| Market cap | $1.89B | $1.96B |
| Today | +1.77% | +1.20% |
| 1 month | +2.2% | +6.0% |
| 6 months | +66.1% | −14.9% |
| Year to date | +31.8% | −13.8% |
| 1 year | +6.7% | −22.8% |
| Revenue growth (YoY) | +28.7% | −34.3% |
| Gross margin | 86.4% | 62.8% |
| Net margin | −33.8% | −1.2% |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | 1.0× |
| Net cash | -$130.8M | -$59.1M |
| Dividend yield | — | — |
| Volatility (60d) | 52.4% | 62.6% |
| Short % of float | 4.6% | 22.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).